Heart Protection w/Dexrazoxane During Chemotherapy
Cardioprotection With Dexrazoxane in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS), Myeloid Blast Phase of Chronic Myeloid Leukemia (CML), Ph+ AML, and Myeloid Blast Phase of Myeloproliferative Neoplasms
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 100 patients (estimated)
- Sponsors
- MD Anderson Cancer Center
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Chemotherapy, Monoclonal Antibody
- Trial Type
- Supportive
- Last Update
- 11 months ago
- SparkCures ID
- 1575
- NCT Identifier
- NCT03589729
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.